Literature DB >> 21147782

Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1.

An Wang1, Uzen Savas, C David Stout, Eric F Johnson.   

Abstract

The atomic structure of human P450 1B1 was determined by x-ray crystallography to 2.7 Å resolution with α-naphthoflavone (ANF) bound in the active site cavity. Although the amino acid sequences of human P450s 1B1 and 1A2 have diverged significantly, both enzymes exhibit narrow active site cavities, which underlie similarities in their substrate profiles. Helix I residues adopt a relatively flat conformation in both enzymes, and a characteristic distortion of helix F places Phe(231) in 1B1 and Phe(226) in 1A2 in similar positions for π-π stacking with ANF. ANF binds in a distinctly different orientation in P450 1B1 from that observed for 1A2. This reflects, in part, divergent conformations of the helix B'-C loop that are stabilized by different hydrogen-bonding interactions in the two enzymes. Additionally, differences between the two enzymes for other amino acids that line the edges of the cavity contribute to distinct orientations of ANF in the two active sites. Thus, the narrow cavity is conserved in both P450 subfamily 1A and P450 subfamily 1B with sequence divergence around the edges of the cavity that modify substrate and inhibitor binding. The conservation of these P450 1B1 active site amino acid residues across vertebrate species suggests that these structural features are conserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147782      PMCID: PMC3037686          DOI: 10.1074/jbc.M110.204420

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Further development and validation of empirical scoring functions for structure-based binding affinity prediction.

Authors:  Renxiao Wang; Luhua Lai; Shaomeng Wang
Journal:  J Comput Aided Mol Des       Date:  2002-01       Impact factor: 3.686

2.  Detection, delineation, measurement and display of cavities in macromolecular structures.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-03-01

3.  Evaluation of comparative protein modeling by MODELLER.

Authors:  A Sali; L Potterton; F Yuan; H van Vlijmen; M Karplus
Journal:  Proteins       Date:  1995-11

4.  Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas.

Authors:  J T Buters; S Sakai; T Richter; T Pineau; D L Alexander; U Savas; J Doehmer; J M Ward; C R Jefcoate; F J Gonzalez
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Structures of human cytochrome P-450 2E1. Insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.

Authors:  Patrick R Porubsky; Kathleen M Meneely; Emily E Scott
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

6.  Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.

Authors:  A Luch; S L Coffing; Y M Tang; A Schneider; V Soballa; H Greim; C R Jefcoate; A Seidel; W F Greenlee; W M Baird; J Doehmer
Journal:  Chem Res Toxicol       Date:  1998-06       Impact factor: 3.739

Review 7.  CYP1B1, a developmental gene with a potential role in glaucoma therapy.

Authors:  D Choudhary; I Jansson; J B Schenkman
Journal:  Xenobiotica       Date:  2009-08       Impact factor: 1.908

8.  Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.

Authors:  Youbin Tu; Rahul Deshmukh; Meena Sivaneri; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2008-08-14       Impact factor: 3.922

Review 9.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

10.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

View more
  46 in total

1.  Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Authors:  An Wang; Uzen Savas; Mei-Hui Hsu; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Specificity determinants of CYP1B1 estradiol hydroxylation.

Authors:  Clinton R Nishida; Steven Everett; Paul R Ortiz de Montellano
Journal:  Mol Pharmacol       Date:  2013-07-02       Impact factor: 4.436

Review 3.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

4.  Predicting drug metabolism by CYP1A1, CYP1A2, and CYP1B1: insights from MetaSite, molecular docking and quantum chemical calculations.

Authors:  Preeti Pragyan; Siddharth S Kesharwani; Prajwal P Nandekar; Vijay Rathod; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2014-07-16       Impact factor: 2.943

5.  Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity.

Authors:  Siddharth S Kesharwani; Prajwal P Nandekar; Preeti Pragyan; Abhay T Sangamwar
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

6.  Kinetic Modeling of Steady-State Situations in Cytochrome P450 Enzyme Reactions.

Authors:  F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2019-08-19       Impact factor: 3.922

Review 7.  Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.

Authors:  F Peter Guengerich; Qian Cheng
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

8.  Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.

Authors:  Tsutomu Shimada; Norie Murayama; Katsuhiro Tanaka; Shigeo Takenaka; F Peter Guengerich; Hiroshi Yamazaki; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2011-07-20       Impact factor: 3.739

9.  Metabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.

Authors:  Tsutomu Shimada; Norie Murayama; Hiroshi Yamazaki; Katsuhiro Tanaka; Shigeo Takenaka; Masayuki Komori; Donghak Kim; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-13       Impact factor: 3.739

10.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.